vimarsana.com

Page 5 - பெருநிறுவன வாழ்க்கைத்தொழில்கள் அரசு உறவுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jazz Pharmaceuticals Announces Proposed Private Offering of Senior Secured Notes

Jazz Pharmaceuticals Announces Proposed Private Offering of Senior Secured Notes News provided by Share this article Share this article DUBLIN, April 20, 2021 /PRNewswire/  Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (the Company ) announced today that its wholly owned subsidiary, Jazz Securities Designated Activity Company (the Issuer ), is commencing a private offering (the Offering ) of senior secured notes (the Notes ) in a transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the Securities Act ), subject to market and other conditions. The Notes will be guaranteed by the Company and certain of the Company s subsidiaries.  If the Offering is consummated, the Company expects to use the net proceeds from the Notes and the acquisition date borrowings under new senior secured credit facilities (the New Senior Secured Credit Facilities ), together with cash on hand  to fund the cash consideration payable in connection with the pr

Jazz Pharmaceuticals Presents Phase 3 Study Results of Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution in Adult Patients with Idiopathic Hypersomnia at 2021 American Academy of Neurology Annual Meeting

(0) Xywav demonstrated statistically significant differences in change in Epworth Sleepiness Scale score (p-value The safety profile in this study was consistent with the known safety profile of Xywav with no new safety signals observed in this population Company to host investor webcast today at 12:30 p.m. ET DUBLIN, April 20, 2021 /PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive results from the Phase 3 study of Xywav TM (calcium, magnesium, potassium, and sodium oxybates) oral solution in adult patients with idiopathic hypersomnia, which will be presented during the Clinical Trials Plenary Session of the 2021 American Academy of Neurology (AAN) Annual Meeting between 10:00 a.m. and 12:30 p.m. ET. Jazz will host an investor and analyst presentation via webcast today at 12:30 p.m. ET.

Jazz Pharmaceuticals to Report 2021 First Quarter Financial Results on May 4, 2021

Jazz Pharmaceuticals to Report 2021 First Quarter Financial Results on May 4, 2021 DUBLIN, April 19, 2021 /PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2021 first quarter financial results on Tuesday, May 4, 2021 after the close of the financial markets. Company management will host a live audio webcast at 4:30 p.m. ET/9:30 p.m. IST to discuss first quarter 2021 financial results and provide a business and financial update. Audio webcast/conference call: International Dial-In Number: +1 503 343 6056 Passcode: 8765706 Replay U.S. Dial-In Number: +1 855 859 2056 Replay International Dial-In Number: +1 404 537 3406 Passcode: 8765706 Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. A replay of the webcast will be archived on the website for at least one week.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.